All Posts: clinical trials

• FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research

  Category: GUMC Stories Tags: cancer, clinical trials, Georgetown Lombardi, lung cancer

• Clinical Research Staff Rise to the Challenges Posed by Pandemic

  (July 31, 2020) — Running clinical research can be complicated under normal circumstances but it’s especially arduous during a pandemic. Despite the difficulties, the clinical research teams at Georgetown have worked tirelessly, remotely and on campus, to continue supporting researchers and study participants. “Our team as a whole really stepped up to do this, and […]

  Category: GUMC Stories Tags: clinical research coordinators, clinical trials, COVID-19, Huntington's disease

• First-of-Its-Kind Clinical Trial at Georgetown Puts Mammography Technologies Under the Spotlight

  Category: GUMC Stories Tags: breast cancer, cancer, clinical trials, Georgetown Lombardi, mammography

• Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial

  WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]

  Category: News Release Tags: Alzheimer's disease, biomedical research, brain, brain research, clinical trials, dementia, mind, nilotinib

• Pressure to Endorse Use of Unproven Drugs for COVID-19 Threatens Public Confidence

  WASHINGTON (April 16, 2020) — The widespread use of experimental treatments for COVID-19, including the antimalarial drugs chloroquine and hydroxychloroquine, represents “ill-advised and uncontrolled human experimentation with unproven treatments,” say two former FDA chief scientists. Furthermore, political pressure or advocacy for specific experimental treatments, such as that surrounding the issuance of an Emergency Use Authorization […]

  Category: News Release Tags: chloroquine, clinical trials, COVID-19, experimental treatments, hydroxychloroquine

• Georgetown Lombardi Clinical Trial Helps Advance Use of Immunotherapy in Liver Cancer

  Category: GUMC Stories Tags: cancer, cancer research, clinical trials, liver cancer

• Nilotinib Appears Safe in Parkinson’s Trial; Drug Thought to Allow Dopamine Replenishment

  WASHINGTON (December 16, 2019) — A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of neuronal destruction, and a decrease in neurotoxic proteins in the brain among […]

  Category: News Release Tags: brain, clinical trials, mind, neurodegenerative disease, neuroscience, Parkinson's disease

• Nearly One-Quarter of Completed Lung Cancer Clinical Trial Results Are Not Published

  Category: News Release Tags: cancer, cancer research, clinical trials

• Virtual Review of Cancer Clinical Trial Treatment Options Quicker Than Conventional Methods

  Category: News Release Tags: biomedical informatics, cancer, clinical trials, Georgetown Lombardi

• Georgetown Offers Multiple Clinical Trials for People with Lewy Body Dementia

  WASHINGTON (October 8, 2019) — Georgetown University Medical Center, a Lewy Body Dementia (LBD) Association Research Center of Excellence, is now offering three clinical trials to study new treatments for LBD, a disease often confused with Parkinson’s and Alzheimer’s disease. Lewy body dementia has similar symptoms to both Parkinson’s and Alzheimer’s diseases — some people […]

  Category: News Release Tags: biomedical research, clinical trials, Lewy body dementia, movement disorders, Translational Neurotherapeutics Program